Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 5/14/24 → 5/14/26 |
Financiación
- United Therapeutics Corporation: 29.908,00 US$
A Randomized, Doubleblind, Placebo-Controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Progressive Pulmonary Fibrosis (TETON-PPF)
- Sen, Parijat (PI)
- Sturgill, Jamie (CoI)